Is a reduction in albuminuria associated with renal and cardiovascular protection? Apost hocanalysis of the ALTITUDE trial
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Is a reduction in albuminuria associated with renal and cardiovascular protection? Apost hocanalysis of the ALTITUDE trial
Authors
Keywords
-
Journal
DIABETES OBESITY & METABOLISM
Volume 18, Issue 2, Pages 169-177
Publisher
Wiley
Online
2015-10-29
DOI
10.1111/dom.12600
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Corrections to "Microalbuminuria: target for renoprotective therapy PRO"
- (2015) KIDNEY INTERNATIONAL
- Treatment of Anemia in Patients With Heart Disease: A Clinical Practice Guideline From the American College of Physicians
- (2015) Amir Qaseem et al. ANNALS OF INTERNAL MEDICINE
- Improved Survival and Renal Prognosis of Patients With Type 2 Diabetes and Nephropathy With Improved Control of Risk Factors
- (2014) Gudbjörg Andrésdóttir et al. DIABETES CARE
- Standards of Medical Care in Diabetes--2014
- (2013) DIABETES CARE
- Reduction and residual proteinuria are therapeutic targets in type 2 diabetes with overt nephropathy: a post hoc analysis (ORIENT-proteinuria)
- (2013) E. Imai et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy
- (2013) Linda F. Fried et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials
- (2013) H. Makani et al. BMJ-British Medical Journal
- Albuminuria, Estimated GFR, Traditional Risk Factors, and Incident Cardiovascular Disease: The PREVEND (Prevention of Renal and Vascular Endstage Disease) Study
- (2012) Paul A. Smink et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- A urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus
- (2012) S. S. Roscioni et al. DIABETOLOGIA
- Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes
- (2012) Hans-Henrik Parving et al. NEW ENGLAND JOURNAL OF MEDICINE
- Albuminuria and blood pressure, independent targets for cardioprotective therapy in patients with diabetes and nephropathy: a post hoc analysis of the combined RENAAL and IDNT trials
- (2011) F. A. Holtkamp et al. EUROPEAN HEART JOURNAL
- Screening for Albuminuria Identifies Individuals at Increased Renal Risk
- (2009) M. van der Velde et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Combining GFR and Albuminuria to Classify CKD Improves Prediction of ESRD
- (2009) S. I. Hallan et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Albuminuria and Kidney Function Independently Predict Cardiovascular and Renal Outcomes in Diabetes
- (2009) T. Ninomiya et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design
- (2009) H.-H. Parving et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Albuminuria: A Great Risk Marker, but an Underestimated Target in Diabetes
- (2008) D. de Zeeuw et al. DIABETES CARE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started